Paragon 28, Inc. (NYSE:FNA) Receives Average Rating of “Hold” from Analysts

Shares of Paragon 28, Inc. (NYSE:FNA) have been given a consensus recommendation of “Hold” by the six analysts that are covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $14.20.

A number of brokerages recently commented on FNA. Stephens reissued an “equal weight” rating and set a $13.00 price target (down from $14.00) on shares of Paragon 28 in a research note on Thursday, January 30th. Canaccord Genuity Group set a $13.00 target price on Paragon 28 in a research report on Wednesday, January 29th. William Blair cut shares of Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, Needham & Company LLC reiterated a “hold” rating and set a $13.00 price objective on shares of Paragon 28 in a research report on Wednesday, January 29th.

Paragon 28 Stock Performance

Shares of NYSE FNA opened at $13.02 on Thursday. The stock has a market cap of $1.09 billion, a PE ratio of -17.59 and a beta of 1.54. Paragon 28 has a 1 year low of $4.65 and a 1 year high of $13.13. The firm has a fifty day moving average price of $12.62 and a 200-day moving average price of $9.73. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60.

Paragon 28 (NYSE:FNA) last issued its quarterly earnings results on Thursday, March 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The business had revenue of $71.75 million during the quarter, compared to analysts’ expectations of $70.81 million. Equities analysts anticipate that Paragon 28 will post -0.64 earnings per share for the current fiscal year.

Insider Activity at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 27,142 shares of the firm’s stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $11.62, for a total value of $315,390.04. Following the completion of the sale, the insider now owns 10,313,841 shares of the company’s stock, valued at $119,846,832.42. This trade represents a 0.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders have sold 1,875,984 shares of company stock worth $24,359,971. Company insiders own 15.32% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Venturi Wealth Management LLC purchased a new position in Paragon 28 during the 4th quarter valued at $36,000. AlphaQuest LLC lifted its position in shares of Paragon 28 by 33.6% during the fourth quarter. AlphaQuest LLC now owns 3,680 shares of the company’s stock worth $38,000 after purchasing an additional 925 shares during the last quarter. State of Wyoming boosted its stake in shares of Paragon 28 by 37.4% during the fourth quarter. State of Wyoming now owns 4,359 shares of the company’s stock valued at $45,000 after purchasing an additional 1,187 shares during the period. Intech Investment Management LLC bought a new position in shares of Paragon 28 in the third quarter worth about $70,000. Finally, KLP Kapitalforvaltning AS purchased a new position in Paragon 28 in the 4th quarter worth about $94,000. Institutional investors own 63.57% of the company’s stock.

About Paragon 28

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.